Correlations between electrophysiological myocardial remodeling and parameters of free radical oxidation in patients with various forms of ischemic heart disease

Terapevticheskii Arkhiv

Volumn 78, Issue 12, 2006, Pages 27-35

  Drinitsina, S V ^a   Azizova, O A ^a   Piryazev, A P ^a   Korinevich, A Yu ^a   Solovyeva, N P ^a   Ivanov, G G ^a   Lopukhin, Yu M ^a  

^a NONE

Author keywords

Electrophysiological remodeling; Free radical oxidation; Ischemic heart disease; Myocardial ischemia; Plasma oxidizability

Indexed keywords

FREE RADICAL; LIPID PEROXIDE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HOSPITALIZATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; FREE RADICALS; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OXIDATION-REDUCTION; SEVERITY OF ILLNESS INDEX; VENTRICULAR REMODELING;

EID: 33846620929     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lussneri B. R. Myocardial ischemia, reperfusion and free radicals injury. Am. J. Cardiol. 1990; 19: 141-213.
2. Russian source
3. Priori S. G. Eartly after depolarisations induced in vivo by reperfusion of ischemic myocardiums. A possible mechanism for reperfusion arrhythmias. Circulation 1990; 81 (6): 1911-1920.
4. Corr P. B., Pogwizd S. M. Mechanisms contributing to arrhythmias mogenesis during early myocardial ischemia, subsequent reperfusion, and cronic infarction. Angiology 1988; 7: 684-699.
5. Burnez R. Reperfusion arrhythmia: myth or reality? Ann. Emerg. Med. 1989; 4: 240-243.
6. Langes K. Arrhythmia as indicator for reperfusion following acute myocardial infarction. Klin. Wschr. 1989; 1 (23): 1199-1204.
7. Podzuweit T. H., Binz K. H., Kennstiol P., Flaig W. The arrhythmias effects of myocardial ischemia. Relation to reperfusion arrhythmia. Cardiovasc. Res. 1989; 23 (2): 81-90.
8. Russian source
9. Tsunoda S., Takeda Y., Takaki H. et al. Utility width measurement to identify ischaemia in hypertensive patients with electrocardiographic left ventricular hypertrophy: high-resolution. In: XXIII Congress of the European society of cardiology. Sept. 1-5, 2001, Stockholm, Sweden. Stockholm; 2001. Abstr. P1106.
10. Allibardi P., Dainese F., Reimers B., Sacca S. Value of QRS duration criteria to detect restenosis after PTCA using ECG stress tecting in patients with single coronary vessel disease. In: XXIII Congress of the European society of cardiology. Sept. 1-5, 2001, Stockholm, Sweden. Stockholm; 2001. Abstr. P1108.
11. Takeda Y., Takaki H., Tahara N. et al. Improved accuracy of exercise in patients with prior myocardial infarction: high-resolution analysis of QRS width. In: XXIII Congress of the European society of cardiology. Sept. 1-5, 2001, Stockholm, Sweden. Stockholm; 2001. Abstr. P1104.
12. Batdorf N. J., Feiveson A. H., Schlegel T. T. Month-to-month and year-to-year reproducibility of high frequency QRS ECG signals. J. Electrocardiol. 2004; 37 (4): 289-296.
13. Tragardh E., Pahlm O., Wagner G. S., Petterson J. Reduced high-frequency QRS components in patients with ischemic heart disease compared to normal subjects. J. Electrocardiol. 2004; 37 (4): 157-161.
14. Ringborn M., Pahlm O., Wagner G. S. et al. The absence of high-frequency QRS changes in the presence of standard electrocardiographic QRS changes of old myocardial infarction. Am. Heart J. 2001; 141: 573.
15. Pettersson J., Carro E., Endenbrandt L. et al. Spatial, individual, and temporal variation of the high-frequency QRS amplitudes in the 12 standard electrocardiographic leads. Am. Heart J. 2000; 139: 352.
16. Schlegel T. T., Kulecz W. B., DePalma J. L. et al. Real-time 12-lead high-frequency electrocardiography for enhanced detection of myocardial ischemia and coronary artery disease. Mayo Clin. Proc. 2004; 79: 339.
17. Pettersson J., Wagner G. S., Lilja O. et al. Standard and high-frequency ECG during reperfusion therapy of acute myocardial infarction. J. Electrocardiol. 2002; 35 (suppl.): 55.
18. Gold M. R., Bloomfield D. M., Anderson K. P. et al. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J. Am. Coll. Cardiol. 2000; 36: 2247.
19. Russian source
20. Russian source
21. Russian source
22. Russian source
23. Russian source
24. Burstein M., Sholnick H. R., Morfin R. Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 1970; 11: 583-595.
25. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499-502.
26. Hess M. L., Manson N. H. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 1996; 20: 707-727.
27. Berliner J. A., Heinnecke J. W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 1996; 20: 707-727.
28. Jessup W. Oxidized lipoproteins and nitric oxide. Curr. Opin. Lipidol. 1996; 7: 274-280.
29. Boulanger C. M., Tanner P. C., Dea M. I. et al. Oxidized LDL induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 1992; 70: 1191-1197.
30. Nijland F., Kamp O., Verhost P. M. et al. In-hospital and long-term prognostic value of viable myocardium detected by dobutamine stress echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular dysfunction. Am. J. Cardiol. 2001; 88: 949-955.
31. DePaoli P., Raimondi L., Lonardo G. et al. Electrophysiological remodelling in the diabetic heart: prevention by angiotensin II receptor bljcade. Eur. Heart J. 2002; 1 (4, abstr. suppl.): 671.
32. Hernandes-Marid A., Rebollo J. G., Rodrigues A. et al. A prospective and randomized study on the effect of an angiotensin II type 1 receptor blocker irbesartan in maintaining sinus rhythm in patients with persistent atrial fibrillation. J. Am. Coll. Cardiol. 2002; 39 (5, suppl. A).
33. Cabrera J. A., Caberstrero F., Quintana D. S. et al. Enalapril prevents early atrial structural remodelling after sustained rapid atrial pacing in a canine model of incuced atrial fibrillation. Eur. Heart J. 2003; 24 (abstr. suppl.): 510.
34. Colivucchi F., Guido, Fecilli et al. Effects of statin therapy on the recurrence of persistent atrial fibrillation in patients with essential hypertension: a propensity score-adjasted analysis. Eur. Heart J. 2002; 1 (abstr. suppl.): 2044.